News
About a dozen activists from the Extinction Rebellion climate group briefly occupied the entrance lobby of French bank BNP ...
Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...
The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
The U.S. Food and Drug Administration has cracked down on compounded drugs, which were readily available while the patented ...
According to a study funded by Eli Lilly, the trial revealed that participants taking tirzepatide, the drug sold as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results